# BIOCEPT INC

BIOCEPT INC is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** BIOCEPT INC
- **Classification:** Company
- **Industry (SIC):** 8071 — Services-Medical Laboratories
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001044378

## About

BIOCEPT INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001044378, and its reported industry is Services-Medical Laboratories. In 10-K filed on 2023-04-17, it reported annual revenue of USD 25,858,000; net income of USD -32,087,000; total assets of USD 30,873,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $25.9M (USD 25,858,000)
- **Net income:** -$32.1M (USD -32,087,000)
- **Total assets:** $30.9M (USD 30,873,000)
- **Operating cash flow:** -$13.3M (USD -13,289,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $61.2M (USD 61,249,000)
- **Net income:** -$2.8M (USD -2,824,000)
- **Total assets:** $60.4M (USD 60,417,000)
- **Operating cash flow:** $3.7M (USD 3,690,000)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $27.5M (USD 27,461,398)
- **Net income:** -$17.8M (USD -17,806,904)
- **Total assets:** $47.5M (USD 47,451,586)
- **Operating cash flow:** -$19.8M (USD -19,787,100)
- **Later filings:** Revenue, Net income, Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $5.5M (USD 5,528,566)
- **Net income:** -$25.1M (USD -25,138,039)
- **Total assets:** $17.7M (USD 17,732,644)
- **Operating cash flow:** -$23.0M (USD -23,049,261)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-10-20 — period 2023-10-16 — FORM 8-K
- Form 8-K — filed 2023-10-16 — period 2023-10-13 — FORM 8-K
- Form 8-K — filed 2023-08-22 — period 2023-08-14 — 8-K
- Form 10-Q — filed 2023-08-14 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-06-21 — period 2023-06-16 — 8-K
- Form SC 13G — filed 2023-06-02
- Form 424B4 — filed 2023-05-25 — 424B4
- Form 8-K — filed 2023-05-16 — period 2023-05-16 — 8-K
- Form 8-K — filed 2023-05-15 — period 2023-05-10 — 8-K
- Form 10-Q — filed 2023-05-10 — period 2023-03-31 — 10-Q
- Form S-1 — filed 2023-04-20 — S-1
- Form DEF 14A — filed 2023-04-20 — period 2023-05-11 — DEF 14A

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/biocept-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology